✦ LIBER ✦

Potentiation of antitumor immunity by antibody-directed enzyme prodrug therapy

✍ Scribed by Bing-Mae Chen; Tian-Lu Cheng; Shey-Cherng Tzou; Steve R. Roffler

Publisher: John Wiley and Sons
Year: 2001
Tongue: French
Weight: 234 KB
Volume: 94
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.1550

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Highly Selective Compounds for the Antib

Highly Selective Compounds for the Antibody-Directed Enzyme Prodrug Therapy of Cancer

✍ Lutz F. Tietze; Tim Feuerstein 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 51 KB

ChemInform Abstract: Prodrugs of Natural

ChemInform Abstract: Prodrugs of Natural Anthracyclines Suited for Antibody-Directed Enzyme Prodrug Therapy (ADEPT) and Prodrug Monotherapy (PMT)

✍ S. Michel; S. Desbene; J.-P. Gesson; C. Monneret; F. Tillequin 📂 Article 📅 2000 🏛 John Wiley and Sons ⚖ 25 KB 👁 1 views

Nitrobenzylcarbamate Prodrugs of Cytotox

Nitrobenzylcarbamate Prodrugs of Cytotoxic Acridines for Potential Use with Nitroreductase Gene Directed Enzyme Prodrug Therapy.

✍ Christian Asche; Pascal Dumy; Daniele Carrez; Alain Croisy; Martine Demeunynck 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 12 KB

Proof of Principle in the Selective Trea

Proof of Principle in the Selective Treatment of Cancer by Antibody-Directed Enzyme Prodrug Therapy: The Development of a Highly Potent Prodrug

✍ Lutz F. Tietze; Tim Feuerstein; Anja Fecher; Frank Haunert; Olaf Panknin; Ulrich 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

Proof of Principle in the Selective Trea

Proof of Principle in the Selective Treatment of Cancer by Antibody-Directed Enzyme Prodrug Therapy: The Development of a Highly Potent Prodrug

✍ Lutz F. Tietze; Tim Feuerstein; Anja Fecher; Frank Haunert; Olaf Panknin; Ulrich 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

Highly Selective Glycosylated Prodrugs o

Highly Selective Glycosylated Prodrugs of Cytostatic CC-1065 Analogues for Antibody-Directed Enzyme Tumor Therapy

✍ Lutz F. Tietze; Tobias Herzig; Anja Fecher; Frank Haunert; Ingrid Schuberth 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

Novel prodrugs of the cytotoxic antibiotic CC-1065 for an antibody-directed enzyme prodrug therapy (ADEPT) were prepared that show an excellent selectivity with a high toxicity of the corresponding drug. In particular, the seco-CBI analogue of CC-1065, 1-chloromethyl-5-hydroxy-1,2-dihydro-3H-benz[e]